Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Rosalba TorrisiRaffaella PalumboRita De SanctisPatrizia ViciGiulia Valeria BianchiLaura CortesiVita LeonardiRossana GueliAlessandra FabiMaria Rosaria ValerioAnna Rita GambaroBarbara TagliaferriLaura PizzutiMarina Elena CazzanigaArmando SantoroPublished in: Breast cancer research and treatment (2021)
The combination of F and T was active in this cohort at poor prognosis and deserves further investigations possibly in combination with pertuzumab in patients with high ER expression.